CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transition
Oncology Research · 2025
DOI: 10.32604/or.2024.050125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Dong Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Epithelial-Mesenchymal Transition, Liver Neoplasms, Transforming Growth Factor beta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
- Department of Neurology, Eastern Hepatobiliary Surgery Hospital, The Third Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
- Department of Hepatic Surgery IV, Shanghai Eastern Hepatobiliary Surgery Hospital, Third Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
Zitieren
APA
Jiang, D., Qi, Z., Xu, Z., & Li, Y. (2025). CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transition. Oncology Research. https://doi.org/10.32604/or.2024.050125
Vancouver
Jiang D, Qi Z, Xu Z, Li Y. CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transition. Oncology Research. 2025. doi:10.32604/or.2024.050125
BibTeX
@article{Jiang2025,
author = {Jiang, Dong and Qi, Zhi and Xu, Zhiying and Li, Yiran},
title = {CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transition},
journal = {Oncology Research},
year = {2025},
doi = {10.32604/or.2024.050125}
}
EUVIMED